These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 29923726)

  • 1. Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells.
    Sun N; Zhao C; Cheng R; Liu Z; Li X; Lu A; Tian Z; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3343-3355. PubMed ID: 29923726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
    Yang Z; Sun N; Cheng R; Zhao C; Liu Z; Li X; Liu J; Tian Z
    Biomaterials; 2017 Dec; 147():53-67. PubMed ID: 28930649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
    Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
    Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
    Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
    Zheng G; Zheng M; Yang B; Fu H; Li Y
    Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.
    Rui M; Qu Y; Gao T; Ge Y; Feng C; Xu X
    Int J Nanomedicine; 2017; 12():217-237. PubMed ID: 28115844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
    Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
    Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin.
    Xu Z; Ni R; Chen Y
    Int J Nanomedicine; 2019; 14():6831-6842. PubMed ID: 31695364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
    Lages EB; Fernandes RS; Andrade MMS; Paiyabhroma N; de Oliveira RB; Fernandes C; Cassali GD; Sicard P; Richard S; Branco de Barros AL; Ferreira LAM
    Biomed Pharmacother; 2021 Dec; 144():112373. PubMed ID: 34794238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
    Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
    Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
    Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
    Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan derivatives functionalized dual ROS-responsive nanocarriers to enhance synergistic oxidation-chemotherapy.
    Liao JX; Huang QF; Li YH; Zhang DW; Wang GH
    Carbohydr Polym; 2022 Apr; 282():119087. PubMed ID: 35123755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.